These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 736688)

  • 1. Subcutaneous administration of somatostatin analogs as a major factor in the enhancement of the duration of action.
    Torchiana ML; Cook PG; Wiese SR; Saperstein R; Veber DF
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):170-6. PubMed ID: 736688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Route of administration as a factor in the selectivity of hormone suppression of a somatostatin analog in rats.
    Lien EL; Garsky VM
    Horm Metab Res; 1981 Dec; 13(12):675-8. PubMed ID: 6119282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-selective inhibition of basal glucagon release by [D-Cys14]-analogues of somatostatin in the rat.
    Märki F; Kamber B; Rink H; Sieber P
    J Endocrinol; 1979 Jun; 81(3):315-23. PubMed ID: 469462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of specific and non-specific somatostatin analogs.
    Nakano T; Harano Y; Emura J; Kimura T; Sakakibara S; Shigeta Y
    Horm Metab Res; 1986 Feb; 18(2):98-102. PubMed ID: 2870971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
    Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM
    Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin analogs inhibit somatostatin release.
    Ipp E; Rivier J; Dobbs RE; Brown M; Vale W; Unger RH
    Endocrinology; 1979 May; 104(5):1270-3. PubMed ID: 436775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of eighteen somatostatin analogues on gastric secretion.
    Brown MP; Coy DH; Gomez-Pan A; Hirst BH; Hunter M; Meyers C; Reed JD; Schally AV; Shaw B
    J Physiol; 1978 Apr; 277():1-14. PubMed ID: 349135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective effect of some somatostatin analogs on glucagon as opposed to insulin release in rats in vivo.
    Lins PE; Efendić S; Meyers CA; Coy DH; Schally A; Luft R
    Metabolism; 1980 Aug; 29(8):728-31. PubMed ID: 6105610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of growth hormone release-inhibiting hormone on gastric secretion, mucosal blood flow, and serum gastrin.
    Konturek SJ; Tasler J; Cieszkowski M; Coy DH; Schally AV
    Gastroenterology; 1976 May; 70(5 PT.1):737-41. PubMed ID: 1261766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of pentagastrin-stimulated acid secretion after subcutaneous administration of a new somatostatin analogue.
    Whitehouse I; Beglinger C; Rüttimann G; Gyr K
    Gut; 1986 Feb; 27(2):141-6. PubMed ID: 2868973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of somatostatin and two of its analogues on basal and arginine-stimulated insulin and glucagon secretion in the dog.
    Buchs A; Märki F; Keller U
    Regul Pept; 1982 Aug; 4(3):117-26. PubMed ID: 6127755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of somatostatin and its analogue, des (Ala1, Gly2) [D-Trp8, D-Asu3,14]-somatostatin (SS-1), on gastric mucosal blood flow and gastric secretion].
    Nishimura T; Sakonjo H; Nakanishi J; Ikeda H; Nomura M; Nishimori T
    Nihon Yakurigaku Zasshi; 1986 May; 87(5):551-6. PubMed ID: 2874104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of somatostatin and prostaglandins on gastric histamine release to pentagastrin.
    Payne NA; Gerber JG
    J Pharmacol Exp Ther; 1992 Nov; 263(2):520-6. PubMed ID: 1279159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of somatostatin inhibition of pentagastrin-stimualted gastric acid secretion.
    Barbezat GO; Kaplan ER; Bowey FS; Berelowitz M; Van Hoorn-Hickman R
    Eur J Pharmacol; 1979 Jan; 53(3):255-9. PubMed ID: 759203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of somatostatin inhibition of insulin-stimulated gastric acid and pepsin secretion in the cat.
    Hirst BH; Reed JD; Shaw B; Coy DH; Schally AV
    Acta Hepatogastroenterol (Stuttg); 1978 Jun; 25(3):208-12. PubMed ID: 352081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of somatostatin receptors involved in inhibition of gastric acid and growth hormone secretion with halogenated Trp8 analogues [proceedings].
    Coy DH; Hirst BH; Meyers CA; Reed JD; Schally AV
    J Physiol; 1978 Dec; 285():40P. PubMed ID: 217989
    [No Abstract]   [Full Text] [Related]  

  • 17. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral and intravenous propantheline bromide on pentagastrin-stimulated canine gastric secretion.
    Dajani EZ; Driskill DR
    Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):243-50. PubMed ID: 686914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
    Neuhaus C; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity studies with somatostatin: the role of tryptophan in position 8.
    Hirst BH; Shaw B; Meyers CA; Coy DH
    Regul Pept; 1980 Oct; 1(2):97-113. PubMed ID: 6114515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.